These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6379352)

  • 21. Developments in experimental leprosy.
    Job CK
    Indian J Lepr; 2000; 72(1):143-54. PubMed ID: 10935192
    [No Abstract]   [Full Text] [Related]  

  • 22. Pathology of a lepromatous eye.
    Ebenezer GJ; Daniel E
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):23-6. PubMed ID: 10834066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo effect of delipidified cell component of Mycobacterium leprae in relation to infection with leprosy bacteria in mice.
    Damle A; Mahadevan PR
    Indian J Lepr; 1993; 65(3):271-82. PubMed ID: 8283062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beige mice infected with Mycobacterium leprae.
    Gelber RH; Scollard DM; Cynamon MH
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):295-7. PubMed ID: 7602228
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccination with DNA of the Mycobacterium tuberculosis 85B antigen protects mouse foot pad against infection with M. leprae.
    Roche PW; Neupane KD; Failbus SS; Kamath A; Britton WJ
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2):93-8. PubMed ID: 11757171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Light and ultrastructural study of sciatic nerve lesions induced using intraneural injection of viable Mycobacterium leprae in normal and immunosuppressed Swiss white mice.
    Shetty VP; Antia NH
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):25-33. PubMed ID: 12120037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of purification and fluorescent staining on viability of Mycobacterium leprae.
    Lahiri R; Randhawa B; Krahenbuhl JL
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):194-202. PubMed ID: 16830641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of freezing Mycobacterium leprae in tissues.
    Dhople AM
    Lepr India; 1982 Jul; 54(3):461-70. PubMed ID: 6757579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine triphosphate content of Mycobacterium leprae: effect of purification procedures.
    Dhople AM; Storrs EE
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):83-9. PubMed ID: 7042615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attempts to cultivate Mycobacterium leprae in fat tissue.
    Godard CM
    Acta Leprol; 1993; 8(3):133-5. PubMed ID: 8213048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression analysis of proteases of Mycobacterium leprae in human skin lesions.
    Ribeiro-Guimarães ML; Tempone AJ; Amaral JJ; Nery JA; Gomes Antunes SL; Pessolani MC
    Microb Pathog; 2007; 43(5-6):249-54. PubMed ID: 17624714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Difference in infectivity of Mycobacterium leprae from patients in immunosuppressed mice (author's transl)].
    Sushida K; Nakano H; Wakai M
    Nihon Rai Gakkai Zasshi; 1981; 50(1):1-7. PubMed ID: 7028712
    [No Abstract]   [Full Text] [Related]  

  • 35. Trophic changes and extensive dissemination in normal mice infected with human Mycobacterium leprae.
    Vaishnavi C; Kaur S; Kumar B; Ganguly NK; Chakravarti RN
    Indian J Lepr; 1984; 56(4):742-7. PubMed ID: 6398338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new model for studying the effects of Mycobacterium leprae on Schwann cell and neuron interactions.
    Hagge DA; Oby Robinson S; Scollard D; McCormick G; Williams DL
    J Infect Dis; 2002 Nov; 186(9):1283-96. PubMed ID: 12402198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of hsp65 DNA vaccination carrying immunostimulatory DNA sequences (CpG motifs) against Mycobacterium leprae multiplication in mice.
    Nomaguchi H; Mukai T; Takeshita F; Matsuoka M; Maeda Y; Aye TM; Jahan N; Yogi Y; Endo M; Sato Y
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):182-90. PubMed ID: 12483966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of tumor necrosis factor-alpha and transforming growth factor-beta in regulating intercellular adhesion molecule-1 expression on murine peritoneal macrophages infected with M. leprae.
    Shimizu T; Maw WW; Tomioka H
    Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):36-45. PubMed ID: 10407627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of cycloserine and structurally related compounds against M. leprae-infected mice.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):536-8. PubMed ID: 6399071
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
    Fieldsteel AH; Levy L
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.